Clinical trial

Impact Assessment of Benazir Nashonuma Program (BNP) on Stunting Prevention Among Children 0-59 Months of Age in Pakistan

Name

BNP Quasi Experimental Study

Description

The aim of the study is to evaluate the impact of Benazir Nashonuma Program (BNP) on prevalence of stunting among under-five children in low income setting of Pakistan. The research question that the study aims to answer is: Is there any change in the prevalence of stunting among under-five children in districts where Benazir Nashonuma Program (BNP) is established compared to districts where BNP is not established? Districts where BNP is functional, and women and children are receiving the intervention will be compared at baseline and end line with control districts where conventional reproductive care services are given. Prevalence of stunting among under-five children will be compared along with other nutritional and growth status indicators over a period of 4 years.

Trial arms

Trial start

2021-12-01

Estimated PCD

2025-12-20

Trial end

2026-06-30

Status

Recruiting

Treatment

Benazir Nashonuma Program (BNP)

Benazir Nashonuma Program (BNP) Dietary supplement for pregnant women and lactating mothers during the first six months of lactation: Maamta is a 75-gram sachet made from peanut butter with 400 kcal of energy Dietary supplement for children aged 6-23 months: Wawamum is a lipid-based nutrient supplement consisting of skimmed milk powder, micronutrients, vegetable oil, roasted chickpeas and antioxidants. Wawamum covers the recommended daily dose of most micronutrients and 255 kcal of energy. Conditional Cash Transfer (CCT): This includes stipends of PKR 2000 during pregnancy contingent on three antenatal care visits, consuming SNF, attending awareness sessions on health and nutrition, getting two doses of tetanus toxoid and institutional delivery. After delivery PKR 2000/- for boys and 2500/- for girls are paid as incentives conditioned on getting child's birth registered, routine immunization and consumption of SNF by the child from 6-23 months

Arms:

Districts with established and operational BNP implementation

Size

13200

Primary endpoint

Baseline to end-line change in the prevalence of stunting among children 0-59 months of age

3 years (on study completion)

Eligibility criteria

All those households are eligible to be included in the study who have: * An under-five child with a mother registered with Benazir Income Support Program (BISP) * Both available at the time of interview Exclusion criteria includes: • Mother of the child who is not a woman of reproductive age, i.e., less than 15 years or greater than 49 years

Protocol

{'studyType': 'INTERVENTIONAL', 'phases': ['NA'], 'designInfo': {'allocation': 'NON_RANDOMIZED', 'interventionModel': 'PARALLEL', 'primaryPurpose': 'PREVENTION', 'maskingInfo': {'masking': 'NONE'}}, 'enrollmentInfo': {'count': 13200, 'type': 'ESTIMATED'}}

Updated at

2023-09-11

1 organization

Organization

Aga Khan University